Compare HCWB & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCWB | DLPN |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 14.6M |
| IPO Year | 2021 | 2008 |
| Metric | HCWB | DLPN |
|---|---|---|
| Price | $3.30 | $1.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 459.2K | 17.7K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.87 |
| EPS | ★ 0.37 | N/A |
| Revenue | $4,099,750.00 | ★ $56,699,389.00 |
| Revenue This Year | N/A | $14.73 |
| Revenue Next Year | N/A | $7.41 |
| P/E Ratio | $10.35 | ★ N/A |
| Revenue Growth | N/A | ★ 9.70 |
| 52 Week Low | $0.25 | $0.99 |
| 52 Week High | $7.35 | $1.88 |
| Indicator | HCWB | DLPN |
|---|---|---|
| Relative Strength Index (RSI) | 51.53 | 45.25 |
| Support Level | $0.37 | $1.05 |
| Resistance Level | $3.89 | $1.70 |
| Average True Range (ATR) | 0.39 | 0.06 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 8.94 | 39.39 |
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.